Iterum Therapeutics ordinary shares removed from Nasdaq listing
Iterum Therapeutics plc's ordinary shares were delisted from the Nasdaq Stock Market on June 23, 2026, for failing to meet continued-listing standards. The removal was initiated by the exchange under Rule 17 CFR 240.12d2-2(b).
Key facts
- Iterum Therapeutics plc ordinary shares delisted from Nasdaq
- Removal effective June 23, 2026
- Basis: failed continued-listing standards under 17 CFR 240.12d2-2(b)
Why it matters
The delisting removes Iterum Therapeutics from Nasdaq trading and eliminates the public market venue for its shares, restricting investor access and likely triggering trading on OTC markets or suspension.
Share
Derived from 25-NSE filed 2026-06-23. Not investment advice. View the source filing on SEC.gov →